Weizman A - Search Results

1

Alterations in brain neurotrophic and glial factors following early age chronic methylphenidate and cocaine administration.

Simchon-Tenenbaum Y, Weizman A, Rehavi M. Simchon-Tenenbaum Y, et al. Among authors: weizman a. Behav Brain Res. 2015 Apr 1;282:125-32. doi: 10.1016/j.bbr.2014.12.058. Epub 2015 Jan 8. Behav Brain Res. 2015. PMID: 25576963

2

Chronic clozapine, but not haloperidol, treatment affects rat brain vesicular monoamine transporter 2.

Rehavi M, Roz N, Weizman A. Rehavi M, et al. Among authors: weizman a. Eur Neuropsychopharmacol. 2002 Jun;12(3):261-8. doi: 10.1016/s0924-977x(02)00021-4. Eur Neuropsychopharmacol. 2002. PMID: 12007678

3

Increased platelet vesicular monoamine transporter density in adult schizophrenia patients.

Zucker M, Valevski A, Weizman A, Rehavi M. Zucker M, et al. Among authors: weizman a. Eur Neuropsychopharmacol. 2002 Aug;12(4):343-7. doi: 10.1016/s0924-977x(02)00041-x. Eur Neuropsychopharmacol. 2002. PMID: 12126874

4

Elevated platelet vesicular monoamine transporter density in untreated patients diagnosed with major depression.

Zucker M, Aviv A, Shelef A, Weizman A, Rehavi M. Zucker M, et al. Among authors: weizman a. Psychiatry Res. 2002 Nov 15;112(3):251-6. doi: 10.1016/s0165-1781(02)00223-8. Psychiatry Res. 2002. PMID: 12450634

5

Decreased limbic vesicular monoamine transporter 2 in a genetic rat model of depression.

Schwartz K, Yadid G, Weizman A, Rehavi M. Schwartz K, et al. Among authors: weizman a. Brain Res. 2003 Mar 7;965(1-2):174-9. doi: 10.1016/s0006-8993(02)04167-7. Brain Res. 2003. PMID: 12591135

6

Education: Teaching pharmacogenomics to prepare future physicians and researchers for personalized medicine.

Gurwitz D, Weizman A, Rehavi M. Gurwitz D, et al. Among authors: weizman a. Trends Pharmacol Sci. 2003 Mar;24(3):122-5. doi: 10.1016/S0165-6147(03)00024-5. Trends Pharmacol Sci. 2003. PMID: 12628356

7

Biochemical and pharmacological characterization of the serotonin transporter in human peripheral blood lymphocytes.

Barkan T, Gurwitz D, Levy G, Weizman A, Rehavi M. Barkan T, et al. Among authors: weizman a. Eur Neuropsychopharmacol. 2004 May;14(3):237-43. doi: 10.1016/S0924-977X(03)00107-X. Eur Neuropsychopharmacol. 2004. PMID: 15056483

8

Influence of 17beta-estradiol on the synthesis of reduced neurosteroids in the brain (in vivo) and in glioma cells (in vitro): possible relevance to mental disorders in women.

Maayan R, Fisch B, Galdor M, Kaplan B, Shinnar N, Kinor N, Zeldich E, Valevski A, Weizman A. Maayan R, et al. Among authors: weizman a. Brain Res. 2004 Sep 10;1020(1-2):167-72. doi: 10.1016/j.brainres.2004.06.025. Brain Res. 2004. PMID: 15312799

9

Decreased platelet vesicular monoamine transporter density in children and adolescents with attention deficit/hyperactivity disorder.

Toren P, Rehavi M, Luski A, Roz N, Laor N, Lask M, Weizman A. Toren P, et al. Among authors: weizman a. Eur Neuropsychopharmacol. 2005 Mar;15(2):159-62. doi: 10.1016/j.euroneuro.2004.07.002. Eur Neuropsychopharmacol. 2005. PMID: 15695060

10

Repeated swim stress leads to down-regulation of vesicular monoamine transporter 2 in rat brain nucleus accumbens and striatum.

Zucker M, Weizman A, Rehavi M. Zucker M, et al. Among authors: weizman a. Eur Neuropsychopharmacol. 2005 Mar;15(2):199-201. doi: 10.1016/j.euroneuro.2004.08.009. Eur Neuropsychopharmacol. 2005. PMID: 15695065

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,055 results

Search Page

Filters